Revvity (RVTY) Research & Development (2009 - 2026)
Revvity's (RVTY) quarterly Research & Development came in at $57.9 million in Q2 2026, up 8.0% YoY from $53.6 million in Q2 2025, and little changed on a QoQ basis from $58.2 million in Q4 2025.
Revvity (RVTY) Research & Development (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Research & Development data on file, last reported at $57.9 million in Q2 2026.
- Quarterly Research & Development rose 8.0% year-over-year to $57.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $220.1 million (up 10.02% YoY) and the FY2025 annual result came in at $215.8 million, up 9.65% from the prior year.
- Research & Development held at $57.9 million in Q2 2026, from $58.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $81.9 million in Q1 2023 to a low of $48.1 million in Q2 2024.
- A 5-year average of $55.1 million and a median of $53.5 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development plunged 39.42% — and 2025, when it advanced 18.22%.
- Tracing RVTY's Research & Development over 5 years: stood at $53.5 million in 2022, then dropped by 7.33% to $49.6 million in 2023, then fell by 0.78% to $49.2 million in 2024, then gained by 18.22% to $58.2 million in 2025, then slipped by 0.5% to $57.9 million in 2026.
- The last three Research & Development figures came in at $57.9 million (Q2 2026), $58.2 million (Q4 2025), and $50.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 364.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 412.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 228.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 126.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 171.28 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 252.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 52.99 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 48.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 48.97 Mn |
| Apr 5, 2026 | 57.89 Mn |
| Dec 28, 2025 | 58.18 Mn |
| Sep 28, 2025 | 50.80 Mn |
| Jun 29, 2025 | 53.27 Mn |
| Mar 30, 2025 | 53.60 Mn |
| Dec 29, 2024 | 49.21 Mn |
| Sep 29, 2024 | 49.14 Mn |
| Jun 30, 2024 | 48.13 Mn |
| Mar 31, 2024 | 50.36 Mn |
| Dec 31, 2023 | 49.60 Mn |
| Oct 1, 2023 | 53.04 Mn |
| Jul 2, 2023 | 57.25 Mn |
| Apr 2, 2023 | 56.69 Mn |
| Jan 1, 2023 | 81.86 Mn |
| Oct 2, 2022 | 53.52 Mn |
| Jul 3, 2022 | 56.04 Mn |
| Apr 3, 2022 | 57.52 Mn |
| Oct 3, 2021 | 49.42 Mn |
| Jul 4, 2021 | 65.82 Mn |